桥接的1,2,4-trioxolanes:SnCl4-催化合成和一个体外研究对S. 曼索尼 在
Peter S Radulov1, Ivan A Yaremenko1, Jennifer Keiser2,3
1N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Moscow 119991, Russia.
Molecules (Basel, Switzerland)
|July 14, 2023
概括
研究人员使用锡化催化剂合成了桥接的1,2,4-trioxolanes (臭氧化物). 这些新型的臭氧化物显示出对Schistosoma mansoni的高抗胞体活性.
科学领域:
- 有机合成 有机合成
- 药用化学 医学化学
- 寄生虫学的寄生虫学
背景情况:
- 桥式1,2,4-trioxolanes,也称为桥式臭氧化物,是有机化合物的一个类.
- 杆菌仍然是一个重大的全球健康问题,需要开发新的治疗药物.
研究的目的:
- 开发一种用于桥接1,2,4-trioxolanes的新型合成方法.
- 为了评估这些合成的化合物的抗胞体活性.
主要方法:
- 从1,5-二基和过氧化中合成桥接的1,2,4-三氧化.
- 使用锡(IV) 化物 (SnCl4) 的催化.
- 对schistosoma mansoni schistosomula和成年虫的抗胞体活性的评估.
主要成果:
- 成功开发了一种新合成的桥接1,2,4-trioxolanes.
- 目标臭氧化物实现了50%至84%的产量.
- 合成的臭氧化物对schistosoma mansoni表现出非常高的活性.
结论:
- (IV) 化物是桥梁臭氧化物合成的有效催化剂.
- 开发的方法允许合成广泛的桥接1,2,4-trioxolanes.
- 这些新型臭氧化物代表了治疗杆菌病的有希望的候选人.
相关概念视频
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...